Click here to


Are you sure ?

Yes, do it No, cancel

Analysis of Pharmacokinetic Modeling and Doxycycline to Quantify Tumor Metabolism Variations Using Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Imaging

J Niedzielski*, J Bankson , K Michel , C Walker , Y Chen , S Lai , UT MD Anderson Cancer Center, Houston, TX


(Sunday, 7/29/2018) 4:00 PM - 6:00 PM

Room: Davidson Ballroom B

Purpose: To develop and validate a methodology for pharmacokinetic modeling of hyperpolarized [1-13C]-pyruvate to probe tumor metabolism in vitro. This method is meant to serve as a foundation for translation and validation of in vivo pharmacokinetic modeling strategies of [1-13C]-pyruvate imaging.

Methods: We developed a closed-system pharmacokinetic model for the conversion of hyperpolarized pyruvate-to-lactate to characterize aerobic glycolysis in vitro. The model was applied to an anaplastic thyroid carcinoma cell-line (Hth83, ~30 million cells/experiment), by quantifying the dynamic conversion of hyperpolarized [1-13C]-pyruvate-to-lactate, using a 300-MHz nuclear magnetic resonance (NMR) spectrometer (Spectrospin 300; Bruker Biospin) and doxycycline to reduce lactate dehydrogenase (LDH). A dynamic nuclear polarizer (HyperSense; Oxford Instruments) was used to produce hyperpolarized pyruvate. A hyperpolarized pyruvate dissolution (125µL, 1-mM pyruvate conc.) was added to Hth83 cells in a 10-mm NMR sample tube. Dynamic 13C spectra were acquired (TR=2s & FA=15°) and exported to Matlab for pharmacokinetic modeling. Additional Hth83 cells were treated with doxycycline (0.1–1.0µg/mL) for 48 hours to knock-down LDH activity and lactate production. Normalized lactate (nLac, normalized by pyruvate) was quantified using the lactate and pyruvate spectra, and the apparent hyperpolarized pyruvate-to-lactate rate constant, ƘPL, was determined by pharmacokinetic analysis of the signal evolution.

Results: Control cell experiments (untreated, n=9) showed highest nLac, followed by 0.1 µg/mL (n=7) and 1.0 µg/mL (n=6) of doxycycline-treated cells (mean±SD=0.153±0.05, 0.106±0.049, 0.087±0.050, respectively) (P=0.012, 0.049, & 0.025, respectively). ƘPL was highest for control cells, followed by 0.1 µg/mL and 1.0 µg/mL of doxycycline-treated cells, (0.805±0.571, 0.451±0.375, 0.224±0.139, respectively) (P=0.018, 0.150, & 0.010, respectively). Normalizing each nLac by total cell count per experiment yielded a linear trend with ƘPL (R=0.80).

Conclusion: Our methodology can serve as a fundamental approach to robustly probe tumor metabolism using hyperpolarized [1-13C]-pyruvate imaging and doxycycline in vitro.


Not Applicable / None Entered.


IM- MRI : Molecular imaging

Contact Email